Literature DB >> 8428037

Coexistence of morphea and systemic sclerosis.

Y Soma1, T Tamaki, K Kikuchi, M Abe, A Igarashi, K Takehara, Y Ishibashi.   

Abstract

While the association of morphea and systemic sclerosis (SSc) is considered to be a rare condition, we observed well-demarcated sclerotic skin changes indistinguishable from morphea in 9 of 135 SSc patients who visited our clinic during the last decade. We consider this rate of incidence (6.7%) to be high enough to consider morphea to be one of the skin involvements of SSc. There was a significantly (p < 0.01) higher incidence of morphea in males (3 of 5) than in females (6 of 130). Only 3 of 111 SSc patients positive for antinuclear antibody (ANA) also showed morphea, whereas 6 of 9 patients negative for ANA showed morphea (p < 0.01). Although the mechanism underlying the development of morphea in SSc patients remains unknown, our observations suggest a heterogeneous pathogenesis related to SSc gender and ANA type.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428037     DOI: 10.1159/000247317

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

Review 1.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

2.  From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution.

Authors:  Dilia Giuggioli; Michele Colaci; Emanuele Cocchiara; Amelia Spinella; Federica Lumetti; Clodovero Ferri
Journal:  Dermatol Res Pract       Date:  2018-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.